Prof. Dr. Ali Ayhan

Türk Jinekoloji ve Obstetrik Derneği (Turkish Society of Gynecology and Obstetrics)

Türk Jinekolojik Onkoloji Derneği (Turkish Society of Gynecologic  Oncology)

Society of Gynecologic Oncology (SGO)

International Gynecologic Cancer  Society

European  Society of Gynecologic Oncology

Middle East and Mediterranean Association of Gynecologic Oncologist

Kadın Hastalıkları ve Doğum

Jinekolojik Onkoloji

1: Ayhan A, Tunç M, Atasoy Karakaş L, Tekelioğlu T, Haberal Reyhan AN, Önalan G,

Kuşçu E. Oncologic and obstetric outcomes of early-stage epithelial ovarian

cancer patients who underwent fertility-sparing surgery: A retrospective study.

Int J Gynaecol Obstet. 2023 Feb 24. doi: 10.1002/ijgo.14732. Epub ahead of

print. PMID: 36825554.

2: Cibula D, Akilli H, Jarkovsky J, van Lonkhuijzen L, Scambia G, Meydanli MM,

Ortiz DI, Falconer H, Abu-Rustum NR, Odetto D, Klát J, Dos Reis R, Zapardiel I,

Di Martino G, Presl J, Laky R, López A, Weinberger V, Obermair A, Pareja R,

Poncová R, Mom C, Bizzarri N, Bor?inová M, Aslan K, Salcedo Hernandez RA, Fons

G, Benešová K, Dostálek L, Ayhan A. Role of adjuvant therapy in intermediate-

risk cervical cancer patients - Subanalyses of the SCCAN study. Gynecol Oncol.

2023 Mar;170:195-202. doi: 10.1016/j.ygyno.2023.01.014. Epub 2023 Jan 25. PMID:

36706646.

3: Bizzarri N, Dostálek L, van Lonkhuijzen LRCW, Giannarelli D, Lopez A,

Falconer H, Querleu D, Ayhan A, Kim SH, Ortiz DI, Klat J, Landoni F, Rodriguez

J, Manchanda R, Kos?un J, Ramirez PT, Meydanli MM, Odetto D, Laky R, Zapardiel

I, Weinberger V, Dos Reis R, Pedone Anchora L, Amaro K, Salehi S, Akilli H, Abu-

Rustum NR, Salcedo-Hernández RA, Jav?rková V, Mom CH, Scambia G, Cibula D.

Association of Hospital Surgical Volume With Survival in Early-Stage Cervical

Cancer Treated With Radical Hysterectomy. Obstet Gynecol. 2023 Jan

1;141(1):207-214. doi: 10.1097/AOG.0000000000005026. Epub 2022 Nov 30. PMID:

36701621.

4: Ok Atılgan A, Özen Ö, Haberal Reyhan AN, Ayhan A. Clinicopathologic Features

and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and

Seromucinous Carcinomas. Int J Surg Pathol. 2022 Nov 30:10668969221134695. doi:

10.1177/10668969221134695. Epub ahead of print. PMID: 36452965.

5: Ayhan A, Akilli H, Abasiyanik MA, Taskiran C. Hyperthermic intraperitoneal

chemotherapy in the treatment of recurrent ovarian cancer: When, and for whom? J

Surg Oncol. 2023 Mar;127(3):457-464. doi: 10.1002/jso.27125. Epub 2022 Oct 20.

PMID: 36264620.

6: Yavas G, Kuscu UE, Ayhan A, Yavas C, Onal C. The utility of 1.5 tesla MR-

guided adaptive stereotactic body radiotherapy for recurrent ovarian tumor -

Case reports and review of the literature. Int J Surg Case Rep. 2022

Oct;99:107696. doi: 10.1016/j.ijscr.2022.107696. Epub 2022 Sep 22. PMID:

36261943; PMCID: PMC9568843.

7: Atilgan AO, Akcay EY, Ozen O, Haberal Reyhan AN, Ayhan A. Microsatellite

Instability Status and the Expression of p16 and Cyclin D1 Proteins in Uterine

Adenosarcoma and Their Clinicopathological Significance. Turk Patoloji Derg.

2023;39(1):31-41. English. doi: 10.5146/tjpath.2022.01580. PMID: 35876683.

8: Ok Atılgan A, Yılmaz Akçay E, Özen Ö, Haberal Reyhan AN, Ayhan A. The

Overexpression of Programmed Death-Ligand 2 in Uterine Adenosarcoma: Correlation

with High-Grade Morphology, Mutant Type TP53 Expression and Clinical Outcomes.

Int J Surg Pathol. 2022 Apr 24:10668969221095189. doi:

10.1177/10668969221095189. Epub ahead of print. PMID: 35466759.

9: Akgor U, Ayhan A, Shushkevich A, Ozdal B, Angelou K, Akbayır O, Kaidarova D,

Ulrikh E, Stepanyan A, Ortac F, Aliyev S, Ozgul N, Taranenka S, Haberal A,

Salman C, Seyhan A, Selcuk I, Haidopoulos D, Akıllı H, Bolatbekova R, Alaverdyan

A, Taskin S, Murshudova S, Batur M, Berlev I, Gultekin M. OPEC study: An

international multicenter study of ovarian preservation in endometrial cancers.

Int J Gynaecol Obstet. 2022 Nov;159(2):550-556. doi: 10.1002/ijgo.14190. Epub

2022 Apr 14. PMID: 35323994.

10: Akilli H, Rahatli S, Aliyeva K, Altundag O, Kuscu UE, Ayhan A. Survival in

recurrent ovarian cancer patients before and after the bevacizumab era: an

observational single-centre study. J Obstet Gynaecol. 2022 Aug;42(6):2230-2234.

doi: 10.1080/01443615.2022.2036967. Epub 2022 Mar 9. PMID: 35260031.

11: Taşdemir Ü, Ceran MU, Önder Dirican A, Akar S, Çelik Ç, Energin H, Görkemli

H, Mammadova N, Çolak E, Ayhan A. Incidence of unexpected leiomyosarcoma in a

Turkish province: a retrospective multi-centre study in a low income setting. J

Obstet Gynaecol. 2022 Aug;42(6):2208-2212. doi: 10.1080/01443615.2022.2036958.

Epub 2022 Mar 7. PMID: 35253591.

12: Altın D, Taşkın S, Ortaç F, Tokgözoğlu N, Vatansever D, Güler AH, Güngör M,

Taşçı T, Beşe T, Turan H, Kahramanoğlu İ, Yalçın İ, Çelik Ç, Demirkıran F, Köse

F, Arvas M, Ayhan A, Taşkıran Ç. Diagnostic accuracy of sentinel node biopsy in

non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A

Turkish gynecologic oncology group study (TRSGO-SLN-006). Gynecol Oncol. 2022

Mar;164(3):492-497. doi: 10.1016/j.ygyno.2022.01.009. Epub 2022 Jan 13. PMID:

35033380.

13: Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Scambia G,

Ayhan A, Kim SH, Isla Ortiz D, Klat J, Obermair A, Di Martino G, Pareja R,

Manchanda R, Kos?un J, Dos Reis R, Meydanli MM, Odetto D, Laky R, Zapardiel I,

Weinberger V, Benešová K, Bor?inová M, Cardenas F, Wallin E, Pedone Anchora L,

Akilli H, Abu-Rustum NR, Barquet-Muñoz SA, Jav?rková V, Fischerová D, van

Lonkhuijzen LRCW. Post-recurrence survival in patients with cervical cancer.

Gynecol Oncol. 2022 Feb;164(2):362-369. doi: 10.1016/j.ygyno.2021.12.018. Epub

2021 Dec 23. PMID: 34955236; PMCID: PMC9406127.

14: Vardar MA, Guzel AB, Taskin S, Gungor M, Ozgul N, Salman C, Kucukgoz-Gulec

U, Khatib G, Taskiran C, Dünder I, Ortac F, Yuce K, Terek C, Simsek T, Ozsaran

A, Onan A, Coban G, Topuz S, Demirkiran F, Takmaz O, Kose MF, Gocmen A,

Seydaoglu G, Gumurdulu D, Ayhan A. Could the Long-Term Oncological Safety of

Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-

Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic

Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-

End-001). Curr Oncol. 2021 Oct 29;28(6):4328-4340. doi:

10.3390/curroncol28060368. PMID: 34898563; PMCID: PMC8628704.

15: Bulutay P, Haberal N, Özen Ö, Erdem Ö, Zeren EH, Kulac İ, Taskiran Ç,

Vatansever D, Ayhan A, Kapucuoğlu N. Reproducibility of Morphologic Parameters

of the International Endocervical Adenocarcinoma Criteria and Classification

System and Correlation With Clinicopathologic Parameters: A Multi-Institutional

Study. Int J Gynecol Pathol. 2022 Sep 1;41(5):447-458. doi:

10.1097/PGP.0000000000000839. Epub 2021 Dec 3. PMID: 34856570.

16: Oz M, Meydanli MM, Altintas MI, Akilli H, Gultekin M, Ozgul N, Salman MC,

Taskin S, Yaprak E, Taskiran C, Vatansever D, Giray B, Yetkinel S, Celik H, Onan

MA, Ayhan A. The safety of major gynaecologic cancer surgery without routine

preoperative COVID-19 testing in the COVID-19 era: a multicentre, retrospective,

case-control study. J Obstet Gynaecol. 2022 Jul;42(5):1286-1292. doi:

10.1080/01443615.2021.1959535. Epub 2021 Oct 25. PMID: 34704523.

17: Cibula D, Dostálek L, Jarkovsky J, Mom CH, Lopez A, Falconer H, Fagotti A,

Ayhan A, Kim SH, Isla Ortiz D, Klat J, Obermair A, Landoni F, Rodriguez J,

Manchanda R, Kos?un J, Dos Reis R, Meydanli MM, Odetto D, Laky R, Zapardiel I,

Weinberger V, Benešová K, Bor?inová M, Pari D, Salehi S, Bizzarri N, Akilli H,

Abu-Rustum NR, Salcedo-Hernández RA, Jav?rková V, Sláma J, van Lonkhuijzen LRCW.

The annual recurrence risk model for tailored surveillance strategy in patients

with cervical cancer. Eur J Cancer. 2021 Oct 16;158:111-122. doi:

10.1016/j.ejca.2021.09.008. Epub ahead of print. PMID: 34666213; PMCID:

PMC9406128.

18: Durmuş Y, Meydanlı MM, Akıllı H, Kayıkçıoğlu F, Güngördük K, Akbayır Ö,

Taşkın S, Çelik H, Ayhan A. Factors associated with the involvement of lymph

nodes in low-grade serous ovarian cancer. J Surg Oncol. 2022 Feb;125(2):264-272.

doi: 10.1002/jso.26700. Epub 2021 Oct 5. PMID: 34610148.

19: Gungorduk K, Muallem J, Aşıcıoğlu O, Gülseren V, Güleç ÜK, Meydanlı MM,

Sehouli J, Özdemir A, Şahin H, Khatib G, Miranda A, Boran N, Şenol T, Yıldırım

N, Turan T, Oge T, Taşkın S, Vardar MA, Ayhan A, Muallem MZ. Survival outcomes

of women with grade 3 endometrioid endometrial cancer: the impact of adjuvant

treatment strategies. Arch Gynecol Obstet. 2022 Mar;305(3):671-681. doi:

10.1007/s00404-021-06187-4. Epub 2021 Aug 27. PMID: 34448946.

20: Günakan E, Akıllı H, Kara AT, Altundağ Ö, Haberal AN, Meydanlı MM, Ayhan A.

Survival impact of number of removed para-aortic lymph nodes in stage I

epithelial ovarian cancer. Arch Gynecol Obstet. 2022 Feb;305(2):459-465. doi:

10.1007/s00404-021-06190-9. Epub 2021 Aug 19. PMID: 34410474.

21: Sercan Ç, Haberal Reyhan AN, Özen Ö, Ayhan A. Clinicopathologic and

Prognostic Significance of CD47 Expression and Tumor-associated Macrophages in

Endometrial Carcinoma. Int J Gynecol Pathol. 2022 Jul 1;41(4):397-406. doi:

10.1097/PGP.0000000000000809. Epub 2021 Jul 19. PMID: 34282107.

22: Akilli H, Gunakan E, Haberal A, Altundag O, Kuscu UE, Taskiran C, Ayhan A.

Complications of cytoreductive surgery plus hyperthermic intraperitoneal

chemotherapy: An evaluation of 100 cases. Int J Gynaecol Obstet. 2022

Mar;156(3):560-565. doi: 10.1002/ijgo.13767. Epub 2021 Jun 17. PMID: 34038007.

23: Taşkın S, Varlı B, Altın D, Takmaz Ö, Vatansever D, Ersöz CC, Turan H,

Bulutay P, Zeren H, Havare SB, Karabük E, Naki M, Güngör M, Köse F, Ortaç F,

Arvas M, Ayhan A, Taşkıran Ç. Comparison of two intraoperative examination

methods for the diagnosis of sentinel lymph node metastasis in clinically early

stage endometrial cancer: A Turkish Gynecologic Oncology Group Study (TRSGO-

SLN-003). Eur J Obstet Gynecol Reprod Biol. 2021 Jun;261:72-77. doi:

10.1016/j.ejogrb.2021.04.009. Epub 2021 Apr 20. PMID: 33894621.

24: Ayhan A, Yilmaz Baran S, Vatansever D, Dogan Durdag G, Akilli H, Celik H,

Taskiran C. Feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) in

ovarian cancer during COVID-19 pandemic. Int J Gynecol Cancer. 2021

Jun;31(6):883-887. doi: 10.1136/ijgc-2021-002511. Epub 2021 Apr 15. PMID:

33858953; PMCID: PMC8054827.

25: Aslan K, Haberal A, Akıllı H, Meydanli MM, Ayhan A. Prognostic value of the

number of the metastatic lymph nodes in locally early-stage cervical cancer:

squamous cell carcinoma versus non-squamous cell carcinoma. Arch Gynecol Obstet.

2021 Nov;304(5):1279-1289. doi: 10.1007/s00404-021-06030-w. Epub 2021 Mar 27.

PMID: 33772630.

26: Ayhan A, Gungorduk K, Khatib G, Fırat Cüylan Z, Boran N, Gökçü M, Çelik H,

Özgül N, Akbayir Ö, Şimşek T, Bakay A, Faruk Köse M, Tunç M, Küçükgöz Güleç Ü,

Koç S, Kuşçu E, Vardar MA, Akilli H, Taskiran C, Mutlu Meydanlı M. Prognostic

factors and survival outcomes of women with uterine leiomyosarcoma: A Turkish

Uterine Sarcoma Group Study-003. Curr Probl Cancer. 2021 Oct;45(5):100712. doi:

10.1016/j.currproblcancer.2021.100712. Epub 2021 Feb 9. PMID: 33685725.

27: Vatansever D, Taskiran C, Mutlu Meydanli M, Gungorduk K, Akbayir O, Yalcin

I, Demirkiran F, Sozen H, Ozgul N, Celik H, Onan MA, Taskin S, Oge T, Simsek T,

Abboud S, Yuksel IT, Ayhan A. Impact of cytoreductive surgery on survival of

patients with low-grade serous ovarian carcinoma: A multicentric study of

Turkish Society of Gynecologic Oncology (TRSGO-OvCa-001). J Surg Oncol. 2021

May;123(8):1801-1810. doi: 10.1002/jso.26450. Epub 2021 Mar 3. PMID: 33657253.

28: Akıllı H, Tohma YA, Günakan E, Küçükyıldız İ, Tunç M, Haberal Reyhan N,

Ayhan A. Factors affecting parametrial involvement in cervical cancer patients

with tumor size ≤4 cm and selection of low-risk patient group. J Turk Ger

Gynecol Assoc. 2021 Feb 24;22(1):37-41. doi:

10.4274/jtgga.galenos.2020.2020.0153. Epub 2021 Jan 28. PMID: 33506671; PMCID:

PMC7944230.

29: Cuylan ZF, Akilli H, Gungorduk K, Demirkiran F, Oz M, Salman MC, Sozen H,

Celik H, Gokcu M, Bese T, Meydanli MM, Ozgul N, Topuz S, Kuscu E, Kuru O, Gokmen

S, Gultekin M, Ayhan A. Is the extent of lymphadenectomy a prognostic factor in

International Federation of Gynecology and Obstetrics stage II endometrioid

endometrial cancer? J Obstet Gynaecol Res. 2021 Mar;47(3):1134-1144. doi:

10.1111/jog.14648. Epub 2021 Jan 10. PMID: 33426779.

30: Ayhan A, Tunc M, Boran N, Khatib G, Gokcu M, Simsek T, Ozen OI, Toptas T,

Yalcin I, Meydanli MM. High-grade endometrial stromal sarcoma versus

undifferentiated uterine sarcoma: a Turkish uterine sarcoma group study-001.

Arch Gynecol Obstet. 2021 Aug;304(2):475-483. doi: 10.1007/s00404-020-05915-6.

Epub 2021 Jan 3. PMID: 33392719.

31: Ayhan A, Toptas T, Oz M, Vardar MA, Kayikcioglu F, Ozgul N, Gokcu M, Simsek

T, Tunc M, Meydanli MM. Low-grade endometrial stromal sarcoma: A Turkish uterine

sarcoma group study analyzing prognostic factors and disease outcomes. Gynecol

Oncol. 2021 Mar;160(3):674-680. doi: 10.1016/j.ygyno.2020.12.017. Epub 2020 Dec

27. PMID: 33375988.

32: Altin D, Taskin S, Tokgozoglu N, Vatansever D, Guler AH, Gungor M, Tasci T,

Turan H, Kahramanoglu I, Yalcin I, Celik C, Kose F, Ortac F, Arvas M, Ayhan A,

Taskiran C. Can risk groups accurately predict non-sentinel lymph node

metastasis in sentinel lymph node-positive endometrial cancer patients? A

Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004). J Surg Oncol. 2021

Feb;123(2):638-645. doi: 10.1002/jso.26310. Epub 2020 Dec 1. PMID: 33259650.

33: Güngördük K, Plett H, Gülseren V, Meydanlı M, Boyraz G, Özdemir İ, Şahin H,

Şenol T, Yıldırım N, Turan T, Öge T, Gökçü M, Taşkın S, Ayhan A, Ataseven B. Is

the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from

That of Grade 3 Endometrioid Adenocarcinoma? Oncol Res Treat.

2021;44(1-2):43-51. doi: 10.1159/000511288. Epub 2020 Nov 27. PMID: 33249415.

34: Ayhan A, Oz M, Topfedaisi Ozkan N, Aslan K, Altintas MI, Akilli H, Demirtas

E, Celik O, Ülgü MM, Birinci S, Meydanli MM. Perioperative SARS-CoV-2 infection

among women undergoing major gynecologic cancer surgery in the COVID-19 era: A

nationwide, cohort study from Turkey. Gynecol Oncol. 2021 Feb;160(2):499-505.

doi: 10.1016/j.ygyno.2020.11.014. Epub 2020 Nov 17. PMID: 33223221; PMCID:

PMC7670981.

35: Gultekin M, Ak S, Ayhan A, Strojna A, Pletnev A, Fagotti A, Perrone AM,

Erzeneoglu BE, Temiz BE, Lemley B, Soyak B, Hughes C, Cibula D, Haidopoulos D,

Brennan D, Cola E, van der Steen-Banasik E, Urkmez E, Akilli H, Zapardiel I,

Tóth I, Sehouli J, Zalewski K, Bahremand K, Chiva L, Mirza MR, Papageorgiou M,

Zoltan N, Adámková P, Morice P, Garrido-Mallach S, Akgor U, Theodoulidis V, Arik

Z, Steffensen KD, Fotopoulou C. Perspectives, fears and expectations of patients

with gynaecological cancers during the COVID-19 pandemic: A Pan-European study

of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).

Cancer Med. 2021 Jan;10(1):208-219. doi: 10.1002/cam4.3605. Epub 2020 Nov 18.

PMID: 33205595; PMCID: PMC7753798.

36: Karakas LA, Atilgan AO, Akilli H, Kuscu UE, Haberal A, Ayhan A. Nulliparity

and postmenopausal status are independent factors of malignancy potential of

endometrial intraepithelial neoplasia in polyps. Int J Gynaecol Obstet. 2021

Mar;152(3):433-438. doi: 10.1002/ijgo.13448. Epub 2020 Dec 15. PMID: 33118172.

37: Ayhan A, Akilli H. Prognostic factors associated with cytoreductive surgery

plus hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer. Int

J Gynaecol Obstet. 2021 Feb;152(2):202-207. doi: 10.1002/ijgo.13410. Epub 2020

Oct 28. PMID: 33020918.

38: Kizilkan Y, Tohma YA, Senel S, Gunakan E, Oguzulgen AI, Aktas BK, Bulut S,

Gokkaya CS, Ozden C, Ozkardes H, Ayhan A. The Effects of Transobturator Tape

Surgery on Sexual Functions in Women With Stress Urinary Incontinence. Sex Med.

2020 Dec;8(4):777-782. doi: 10.1016/j.esxm.2020.08.001. Epub 2020 Sep 3. PMID:

32891593; PMCID: PMC7691869.

39: Bhandoria GP, Bhandarkar P, Ahuja V, Maheshwari A, Sekhon RK, Gultekin M,

Ayhan A, Demirkiran F, Kahramanoglu I, Wan YL, Knapp P, Dobroch J, Zmaczy?ski A,

Jach R, Nelson G. Enhanced Recovery After Surgery (ERAS) in gynecologic

oncology: an international survey of peri-operative practice. Int J Gynecol

Cancer. 2020 Oct;30(10):1471-1478. doi: 10.1136/ijgc-2020-001683. Epub 2020 Aug

4. PMID: 32753562.

40: Günakan E, Tohma YA, Karakaş LA, Akıllı H, Haberal AN, Ayhan A. Prognostic

impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer.

Obstet Gynecol Sci. 2020 Jul;63(4):464-469. doi: 10.5468/ogs.19204. Epub 2020

Jun 19. PMID: 32550735; PMCID: PMC7393742.

41: Altin D, Taşkın S, Kahramanoglu I, Vatansever D, Tokgozoglu N, Karabük E,

Turan H, Takmaz Ö, Naki MM, Güngör M, Köse MF, Ortac F, Arvas M, Ayhan A,

Taskiran C. Combination of sentinel lymph node mapping and uterine frozen

section examination to reduce side-specific lymphadenectomy rate in endometrial

cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002). Int J

Gynecol Cancer. 2020 Jul;30(7):1005-1011. doi: 10.1136/ijgc-2020-001353. Epub

2020 May 30. PMID: 32474451.

42: Ayhan A, Tohma YA, Tunc M. Fertility preservation in early-stage endometrial

cancer and endometrial intraepithelial neoplasia: A single-center experience.

Taiwan J Obstet Gynecol. 2020 May;59(3):415-419. doi:

10.1016/j.tjog.2020.03.014. PMID: 32416890.

43: Aslan K, Meydanli MM, Akilli H, Durmuş Y, Gökçü M, Kayıkçıoğlu F, Demirkiran

F, Ayhan A. Does lymph node ratio have any prognostic significance in maximally

cytoreduced node-positive low-grade serous ovarian carcinoma? Arch Gynecol

Obstet. 2020 Jul;302(1):183-190. doi: 10.1007/s00404-020-05580-9. Epub 2020 May

14. PMID: 32409929.

44: Gultekin M, Guler OC, Yuce Sari S, Akkus Yildirim B, Onal C, Celik H, Yuce

K, Ayhan A, Arik Z, Kose F, Altundag O, Zoto Mustafayev T, Atalar B, Bolukbasi

Y, Yildiz F. Multi-institutional validation of the ESMO-ESGO-ESTRO consensus

conference risk grouping in Turkish endometrial cancer patients treated with

comprehensive surgical staging. J Obstet Gynaecol. 2021 Apr;41(3):414-420. doi:

10.1080/01443615.2020.1737661. Epub 2020 Apr 29. PMID: 32347768.

45: Dilaver E, Suzen M, Demir O, Iric S, Ayhan AO, Uckan S. Changes of Stress

Distributions Around Pterygomaxillary Junction With Different Osteotome

Angulations. J Craniofac Surg. 2020 Sep;31(6):1560-1562. doi:

10.1097/SCS.0000000000006397. PMID: 32310867.

46: Akilli H, Tohma YA, Bulut AN, Karakas LA, Haberal AN, Kuscu UE, Ayhan A.

Comparison of no adjuvant treatment and radiotherapy in early-stage cervical

carcinoma with intermediate risk factors. Int J Gynaecol Obstet. 2020

Jun;149(3):298-302. doi: 10.1002/ijgo.13147. Epub 2020 Apr 22. PMID: 32246761.

47: Günakan E, Tohma YA, Tunç M, Akıllı H, Şahin H, Ayhan A. Factors associated

with surgical morbidity of primary debulking in epithelial ovarian cancer.

Obstet Gynecol Sci. 2020 Jan;63(1):64-71. doi: 10.5468/ogs.2020.63.1.64. Epub

2019 Dec 31. PMID: 31970129; PMCID: PMC6962589.

48: Taşkın S, Altin D, Vatansever D, Tokgozoglu N, Karabük E, Turan H, Takmaz Ö,

Kahramanoglu I, Naki MM, Güngör M, Köse F, Ortac F, Arvas M, Ayhan A, Taskiran

C. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish

gynecologic oncology group study (TRSGO-SLN-001). Int J Gynecol Cancer. 2020

Mar;30(3):299-304. doi: 10.1136/ijgc-2019-000847. Epub 2019 Dec 18. PMID:

31857440.

49: Aslan K, Meydanli MM, Oz M, Tohma YA, Haberal A, Ayhan A. The prognostic

value of lymph node ratio in stage IIIC cervical cancer patients triaged to

primary treatment by radical hysterectomy with systematic pelvic and para-aortic

lymphadenectomy. J Gynecol Oncol. 2020 Jan;31(1):e1. doi:

10.3802/jgo.2020.31.e1. Epub 2019 Jun 24. PMID: 31788991; PMCID: PMC6918892.

50: Yorgancı A, Meydanlı MM, Kadıoğlu N, Taşkın S, Kayıkçıoğlu F, Altın D,

Atasoy L, Haberal AN, Kınay T, Akgül MA, Tapısız ÖL, Evliyaoğlu Ö, Tekin ÖM,

Fırat Ortaç U, Ayhan A. Incidence and outcome of occult uterine sarcoma: A

multi-centre study of 18604 operations performed for presumed uterine leiomyoma.

J Gynecol Obstet Hum Reprod. 2020 Jan;49(1):101631. doi:

10.1016/j.jogoh.2019.101631. Epub 2019 Sep 6. PMID: 31499285.

51: Gurkan D, Ceren Akin A, Sahin H, Aytac Tohma Y, Sahin EA, Gunakan E,

Iflazoglu N, Nihan Haberal A, Ayhan A. Oncologic outcomes in patients undergoing

maximal or optimal cytoreductive surgery for Stage 3C serous ovarian, tubal or

peritoneal carcinomas. J Obstet Gynaecol. 2020 May;40(4):551-557. doi:

10.1080/01443615.2019.1634028. Epub 2019 Sep 4. PMID: 31482736.

52: Kahramanoglu I, Meydanli MM, Taranenka S, Ayhan A, Salman C, Sanci M,

Demirkiran F, Ortac F, Haidopoulos D, Sukhin V, Kaidarova D, Stepanyan A,

Farazaneh F, Aliyev S, Ulrikh E, Kurdiani D, Yalcin İ, Mavrichev S, Akilli H,

Sarı ME, Pletnev A, Aslan K, Bese T, Kairbayev M, Vlachos D, Gultekin M. SATEN

III-Splitting Adjuvant Treatment of stage III ENdometrial cancers: an

international, multicenter study. Int J Gynecol Cancer. 2019

Oct;29(8):1271-1279. doi: 10.1136/ijgc-2019-000643. Epub 2019 Sep 2. PMID:

31481453.

53: Selcuk I, Meydanli MM, Yalcin I, Gungorduk K, Akgol S, Çelik H, Ayhan A.

Comparison of survival outcomes in optimally and maximally cytoreduced stage

IIIC ovarian high-grade serous carcinoma: Women with only peritoneal tumor

burden versus women with both peritoneal and lymphogenous dissemination. J

Obstet Gynaecol Res. 2019 Oct;45(10):2074-2081. doi: 10.1111/jog.14075. Epub

2019 Aug 1. PMID: 31373110.

54: Ayhan A, Aslan K, Bulut AN, Akilli H, Öz M, Haberal A, Meydanli MM. Is the

revised 2018 FIGO staging system for cervical cancer more prognostic than the

2009 FIGO staging system for women previously staged as IB disease? Eur J Obstet

Gynecol Reprod Biol. 2019 Sep;240:209-214. doi: 10.1016/j.ejogrb.2019.07.002.

Epub 2019 Jul 6. PMID: 31325847.

55: Ayhan A, Aslan K, Öz M, Tohma YA, Kuşçu E, Meydanli MM. Para-aortic lymph

node involvement revisited in the light of the revised 2018 FIGO staging system

for cervical cancer. Arch Gynecol Obstet. 2019 Sep;300(3):675-682. doi:

10.1007/s00404-019-05232-7. Epub 2019 Jul 1. PMID: 31263988.

56: Şahin H, Karatas F, Coban G, Özen Ö, Erdem Ö, Onan MA, Ayhan A. Uterine

smooth muscle tumor of uncertain malignant potential: fertility and clinical

outcomes. J Gynecol Oncol. 2019 Jul;30(4):e54. doi: 10.3802/jgo.2019.30.e54.

Epub 2019 Feb 4. PMID: 31074239; PMCID: PMC6543118.

57: Akilli H, Rahatli S, Tohma YA, Karakas LA, Altundag O, Ayhan A. Effect of

increased number of neoadjuvant chemotherapy cycles on tumor resectability and

pathologic response in advanced stage epithelial ovarian cancer. J BUON. 2018

Dec;23(7):111-115. PMID: 30722119.

58: Günakan E, Atan S, Haberal AN, Küçükyıldız İA, Gökçe E, Ayhan A. A novel

prediction method for lymph node involvement in endometrial cancer: machine

learning. Int J Gynecol Cancer. 2019 Feb;29(2):320-324. doi:

10.1136/ijgc-2018-000033. Epub 2018 Dec 28. PMID: 30718313.

59: Ayhan A, Şahin H, Sari ME, Yalçin I, Haberal A, Meydanli MM. Prognostic

significance of lymphovascular space invasion in low-risk endometrial cancer.

Int J Gynecol Cancer. 2019 Mar;29(3):505-512. doi: 10.1136/ijgc-2018-000069.

Epub 2019 Jan 21. PMID: 30665899.

60: Sahin H, Meydanli MM, Sari ME, Kocaman E, Cuylan ZF, Yalcin I, Coban G, Özen

Ö, Sirvan L, Güngör T, Ayhan A. Recurrence patterns and prognostic factors in

lymphovascular space invasion-positive endometrioid endometrial cancer

surgically confined to the uterus. Taiwan J Obstet Gynecol. 2019

Jan;58(1):82-89. doi: 10.1016/j.tjog.2018.11.016. PMID: 30638487.

61: Sarı ME, Meydanlı MM, Yalçın I, Şahin H, Çoban G, Çelik H, Kuşçu E, Gungor

T, Ayhan A. Risk Factors for Lymph Node Metastasis among Lymphovascular Space

Invasion-Positive Women with Endometrioid Endometrial Cancer Clinically Confined

to the Uterus. Oncol Res Treat. 2018;41(12):750-754. doi: 10.1159/000492585.

Epub 2018 Nov 13. PMID: 30419557.

62: Firat Cuylan Z, Karabuk E, Oz M, Turan AT, Meydanli MM, Taskin S, Sari ME,

Sahin H, Ulukent SC, Akbayir O, Gungorduk K, Gungor T, Kose MF, Ayhan A.

Comparison of stage III mucinous and serous ovarian cancer: a case-control

study. J Ovarian Res. 2018 Oct 30;11(1):91. doi: 10.1186/s13048-018-0464-2.

PMID: 30376858; PMCID: PMC6208168.

63: Ayhan A, Tohma YA, Sahin H, Kocaman E, Tunc M, Haberal AN. Oncological and

obstetric outcomes after fertility-sparing radical abdominal trachelectomy for

early stage cervical cancer: a tertiary centre's 10 years' experience. J Obstet

Gynaecol. 2019 Feb;39(2):248-252. doi: 10.1080/01443615.2018.1498830. Epub 2018

Oct 27. PMID: 30371139.

64: Ayhan A, Akilli H, Haberal N. The prognostic significance of stage I ovarian

clear cell and endometrioid carcinomas arising from endometriotic cysts: is it a

myth? Arch Gynecol Obstet. 2019 Jan;299(1):217-222. doi:

10.1007/s00404-018-4935-x. Epub 2018 Oct 12. PMID: 30315413.

65: Günakan E, Tohma YA, Haberal AN, Ayhan A. Bilateral synchronous ovarian

tumours: an uncommon case and review of the literature. Prz Menopauzalny. 2018

Jun;17(2):97-100. doi: 10.5114/pm.2018.77312. Epub 2018 Jun 30. PMID: 30150919;

PMCID: PMC6107091.

66: Tohma YA, Zeyneloglu HB, Aslan OD, Haberal AN, Onalan G, Ayhan A. Prevalence

of endometrial cancer or atypical hyperplasia diagnosed incidentally in

infertility clinic. Am J Obstet Gynecol. 2018 Nov;219(5):503-505. doi:

10.1016/j.ajog.2018.08.008. Epub 2018 Aug 15. PMID: 30118694.

67: Güngördük K, Firat Cüylan Z, Kahramanoglu I, Oge T, Akbayir O, Dede M,

Taşkın S, Ozgul N, Simsek T, Turan H, Gülseren V, Ozdemir A, Meydanlı MM, Ayhan

A. Risk Factors for Recurrence in Low-Risk Endometrial Cancer: A Case-Control

Study. Oncol Res Treat. 2018;41(7-8):466-470. doi: 10.1159/000488112. Epub 2018

Jul 6. PMID: 30056447.

68: Tohma YA, Akilli H, Kirnap M, Haberal AN, Akyel D, Zengin HY, Zeyneloglu HB,

Kuscu E, Ayhan A, Haberal M. Possible impact of immunosuppressive therapy

regimens on histopathologic outcomes of abnormal uterine bleeding in solid-organ

transplant recipients. Clin Transplant. 2018 Aug;32(8):e13305. doi:

10.1111/ctr.13305. Epub 2018 Jun 15. PMID: 29851156.

69: Ayhan A, Topfedaisi Ozkan N, Öz M, Kimyon Comert G, Firat Cuylan Z, Çoban G,

Turkmen O, Erdem B, Şahin H, Akbayır Ö, Dede M, Turan AT, Celik H, Güngör T,

Haberal A, Arvas M, Meydanli MM. Impact of lymph node ratio on survival in stage

IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group

study. J Gynecol Oncol. 2018 Jul;29(4):e48. doi: 10.3802/jgo.2018.29.e48. Epub

2018 Mar 13. PMID: 29770619; PMCID: PMC5981100.

70: Cuylan ZF, Meydanli MM, Sari ME, Akbayir O, Celik H, Dede M, Sahin H,

Gungorduk K, Kuscu E, Ozgul N, Gungor T, Ayhan A. Prognostic factors for

maximally or optimally cytoreduced stage III nonserous epithelial ovarian

carcinoma treated with carboplatin/paclitaxel chemotherapy. J Obstet Gynaecol

Res. 2018 Jul;44(7):1284-1293. doi: 10.1111/jog.13663. Epub 2018 May 4. PMID:

29727055.

71: Cuylan ZF, Oz M, Ozkan NT, Comert GK, Sahin H, Turan T, Akbayir O, Kuscu E,

Celik H, Dede M, Gungor T, Meydanli MM, Ayhan A. Prognostic factors and patterns

of recurrence in lymphovascular space invasion positive women with stage IIIC

endometriod endometrial cancer. J Obstet Gynaecol Res. 2018 Jun;44(6):1140-1149.

doi: 10.1111/jog.13615. Epub 2018 Mar 8. PMID: 29516573.

72: Sahin H, Meydanli MM, Sari ME, Yalcin I, Çoban G, Ozkan NT, Cuylan ZF, Erdem

B, Gungorduk K, Akbayir Ö, Dede M, Salman MC, Güngör T, Ayhan A. Does the

primary route of spread have a prognostic significance in stage III non-serous

epithelial ovarian cancer? J Ovarian Res. 2018 Mar 5;11(1):21. doi:

10.1186/s13048-018-0393-0. PMID: 29506569; PMCID: PMC5838854.

73: Sahin H, Sari ME, Cuylan ZF, Haberal AN, Sirvan L, Coban G, Yalcin I, Güngör

T, Celik H, Meydanli MM, Ayhan A. Is the presence of endometriosis associated

with a survival benefit in pure ovarian clear cell carcinoma? Arch Gynecol

Obstet. 2018 Apr;297(4):1005-1013. doi: 10.1007/s00404-018-4651-6. Epub 2018 Jan

30. PMID: 29383437.

74: Ayhan A, Ozkan NT, Sarı ME, Celik H, Dede M, Akbayır Ö, Güngördük K, Şahin

H, Haberal A, Güngör T, Arvas M, Meydanlı MM. Impact of lymph node ratio on

survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic

Oncology Group study. J Gynecol Oncol. 2018 Jan;29(1):e12. doi:

10.3802/jgo.2018.29.e12. PMID: 29185270; PMCID: PMC5709522.

75: Yalcin I, Meydanli MM, Turan AT, Taskin S, Sari ME, Gungor T, Akbayir O,

Ayhan A. Carcinosarcoma of the ovary compared to ovarian high-grade serous

carcinoma: impact of optimal cytoreduction and standard adjuvant treatment. Int

J Clin Oncol. 2018 Apr;23(2):329-337. doi: 10.1007/s10147-017-1215-x. Epub 2017

Nov 16. PMID: 29143144.

76: Korkmaz V, Meydanli MM, Yalçın I, Sarı ME, Sahin H, Kocaman E, Haberal A,

Dursun P, Güngör T, Ayhan A. Comparison of three different risk-stratification

models for predicting lymph node involvement in endometrioid endometrial cancer

clinically confined to the uterus. J Gynecol Oncol. 2017 Nov;28(6):e78. doi:

10.3802/jgo.2017.28.e78. PMID: 29027396; PMCID: PMC5641528.

77: Ayhan A, Günakan E, Alyazıcı İ, Haberal N, Altundağ Ö, Dursun P. The

preoperative albumin level is an independent prognostic factor for optimally

debulked epithelial ovarian cancer. Arch Gynecol Obstet. 2017

Nov;296(5):989-995. doi: 10.1007/s00404-017-4511-9. Epub 2017 Sep 5. PMID:

28875365.

78: Topfedaisi Ozkan N, Meydanlı MM, Sarı ME, Demirkiran F, Kahramanoglu I, Bese

T, Arvas M, Şahin H, Haberal A, Celik H, Coban G, Oge T, Yalcin OT, Akbayır Ö,

Erdem B, Numanoğlu C, Özgül N, Boyraz G, Salman MC, Yüce K, Dede M, Yenen MC,

Taşkın S, Altın D, Ortaç UF, Aydın Ayık H, Şimşek T, Güngör T, Güngördük K,

Sancı M, Ayhan A. Factors associated with survival after relapse in patients

with low-risk endometrial cancer treated with surgery alone. J Gynecol Oncol.

2017 Sep;28(5):e65. doi: 10.3802/jgo.2017.28.e65. Epub 2017 Jun 16. PMID:

28657226; PMCID: PMC5540724.

79: Sarı ME, Meydanlı MM, Türkmen O, Cömert GK, Turan AT, Karalök A, Şahin H,

Haberal A, Kocaman E, Akbayır Ö, Erdem B, Numanoğlu C, Güngördük K, Sancı M,

Gökçü M, Özgül N, Salman MC, Boyraz G, Yüce K, Güngör T, Taşkın S, Altın D,

Ortaç UF, Ayık HA, Şimşek T, Arvas M, Ayhan A. Prognostic factors and treatment

outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a

Turkish Gynecologic Oncology Group study. J Gynecol Oncol. 2017 Jul;28(4):e49.

doi: 10.3802/jgo.2017.28.e49. PMID: 28541637; PMCID: PMC5447148.

80: Dursun P, Ayhan A. Gynecologic Oncologist Perspective About ESMO-ESGO-ESTRO

Consensus Conference on Endometrial Cancer. Int J Gynecol Cancer. 2017

May;27(4):826-831. doi: 10.1097/IGC.0000000000000931. PMID: 28441254.

81: Ayhan A, Ozler A, Dursun P, Haberal AN. Potential role of increasing number

of sections in frozen section diagnosis of ovarian tumors. J Exp Ther Oncol.

2016 Nov;11(4):245-250. PMID: 27849334.

82: Akkuzu G, Kurt G, Guvenc G, Kok G, Simsek S, Dogrusoy S, Ayhan A. Learning

Needs of Gynecologic Cancer Survivors. J Cancer Educ. 2018 Jun;33(3):544-550.

doi: 10.1007/s13187-016-1118-y. PMID: 27743314.

83: Karakaya BK, Başer E, Bildacı B, Cömert EÇ, Bayraktar N, Dursun P, Kuşçu E,

Ayhan A. Alternative tumor markers in the diagnosis of ovarian cancer. Ginekol

Pol. 2016;87(8):565-769. doi: 10.5603/GP.2016.0045. PMID: 27629130.

84: Tuncer HA, Ozgul N, Kuscu E, Dursun P, Ayhan A. Evaluation of a New

Oncogynecologic Training Program. Int J Gynecol Cancer. 2016 Sep;26(7):1333-7.

doi: 10.1097/IGC.0000000000000748. PMID: 27465887.

85: Ayhan A, Tuncer HA, Reyhan NH, Kuscu E, Dursun P. Risk factors for residual

disease after cervical conization in patients with cervical intraepithelial

neoplasia grades 2 and 3 and positive surgical margins. Eur J Obstet Gynecol

Reprod Biol. 2016 Jun;201:1-6. doi: 10.1016/j.ejogrb.2016.03.021. Epub 2016 Mar

24. PMID: 27038228.

86: Qzler A, Dogan S, Mamedbeyli G, Rahatli S, Haberal AN, Dursun P, Ayhan A.

Primary yolk sac tumor of endometrium: report of two cases and review of

literature. J Exp Ther Oncol. 2015;11(1):5-9. PMID: 26259383.

87: Gulumser C, Tuncer A, Kuscu E, Ayhan A. Is colposcopic evaluation necessary

in all women with postcoital bleeding? Eur J Obstet Gynecol Reprod Biol. 2015

Oct;193:83-7. doi: 10.1016/j.ejogrb.2015.06.012. Epub 2015 Jun 22. PMID:

26254856.

88: Karabuga H, Gultekin M, Tulunay G, Yuce K, Ayhan A, Yuce D, Yildiz F.

Assessing the Quality of Life in Patients With Endometrial Cancer Treated With

Adjuvant Radiotherapy. Int J Gynecol Cancer. 2015 Oct;25(8):1526-33. doi:

10.1097/IGC.0000000000000509. PMID: 26207785.

89: Tuncer HA, Kirnap M, Dursun P, Ayhan A, Moray G, Haberal M. Cervical

Carcinoma in a Renal Transplant Recipient: A Case Report. Exp Clin Transplant.

2016 Feb;14(1):100-2. doi: 10.6002/ect.2014.0057. Epub 2015 Mar 24. PMID:

25807337.

90: Dursun P, Doğan NU, Ayhan A. Oncofertility for gynecologic and non-

gynecologic cancers: fertility sparing in young women of reproductive age. Crit

Rev Oncol Hematol. 2014 Dec;92(3):258-67. doi: 10.1016/j.critrevonc.2014.07.001.

Epub 2014 Jul 22. PMID: 25090914.

91: Destelı GA, Demıralay E, Gürsu T, Ayhan A. Detection of HPV positivity by

immunohistochemistry in colposcopic cervical biopsies with a cytological

diagnosis of ASCUS. Turk Patoloji Derg. 2014;30(3):166-70. doi:

10.5146/tjpath.2014.01267. PMID: 24994615.

92: Rahatli S, Dizdar O, Kucukoztas N, Oguz A, Yalcin S, Ozen O, Reyhan NH,

Tarhan C, Yildiz F, Dursun P, Altundag O, Ayhan A. Good outcomes of patients

with stage IB endometrial cancer with surgery alone. Asian Pac J Cancer Prev.

2014;15(9):3891-3. doi: 10.7314/apjcp.2014.15.9.3891. PMID: 24935569.

93: Altin C, Sade LE, Demirtas S, Karacaglar E, Kanyilmaz S, Simsek V, Ayhan A,

Muderrisoglu H. Effects of Paclitaxel and Carboplatin combination on mechanical

myocardial and microvascular functions: a transthoracic Doppler echocardiography

and two-dimensional strain imaging study. Echocardiography. 2015

Feb;32(2):238-47. doi: 10.1111/echo.12621. Epub 2014 May 9. PMID: 24814007.

94: Dursun P, Tezcaner T, Zeyneloglu HB, Alyazıcı I, Haberal A, Ayhan A. Adnexal

Masses Treated Using a Combination of the SILS Port and Noncurved Straight

Laparoscopic Instruments: Turkish Experience and Review of the Literature. Minim

Invasive Surg. 2013;2013:836380. doi: 10.1155/2013/836380. Epub 2013 Nov 11.

PMID: 24307944; PMCID: PMC3836423.

95: Dursun P, Caglar M, Akilli H, Ayhan A. Large conization and laparoendoscopic

single-port pelvic lymphadenectomy in early-stage cervical cancer for fertility

preservation. Case Rep Surg. 2013;2013:207191. doi: 10.1155/2013/207191. Epub

2013 Oct 7. PMID: 24223319; PMCID: PMC3816043.

96: Dursun P, Ayhan A, Mutlu L, Çağlar M, Haberal A, Güngör T, Özat M, Özgü E,

Onan A, Taşkiran C, Güner H, Yetımalar H, Kasap B, Yüce K, Salman MC, Sayal B,

Doğan S, Harma M, Harma M, Basaran M, Aydoğmuş H, Ergün Y, Şehıralı S, Gültekın

E, Köse S, Yildirim Y, Yenen M, Dede M, Alanbay I, Karaca R, Metındır J, Keskın

L, Üstüner I, Avşar F, Yüksel H, Kirdar S. HPV types in Turkey: multicenter

hospital based evaluation of 6388 patients in Turkish gynecologic oncology group

centers. Turk Patoloji Derg. 2013;29(3):210-6. doi: 10.5146/tjpath.2013.01188.

PMID: 24022311.

97: Guvenal T, Dursun P, Hasdemir PS, Hanhan M, Guven S, Yetimalar H, Goksedef

BP, Sakarya DK, Doruk A, Terek MC, Saatli B, Guzin K, Corakci A, Deger E, Celik

H, Cetin A, Ozsaran A, Ozbakkaloglu A, Kolusari A, Celik C, Keles R, Sagir FG,

Dilek S, Uslu T, Dikmen Y, Altundag O, Ayhan A. Effect of surgical staging on

539 patients with borderline ovarian tumors: a Turkish Gynecologic Oncology

Group study. Gynecol Oncol. 2013 Dec;131(3):546-50. doi:

10.1016/j.ygyno.2013.08.038. Epub 2013 Sep 7. PMID: 24016409.

98: Dursun P, Ayhan A. A novel and objective pathological classification system

for radical hysterectomy (RH): an initial proposal. Int J Gynecol Cancer. 2013

Sep;23(7):1168-9. doi: 10.1097/IGC.0b013e31829ededc. PMID: 23970152.

99: Akkuzu G, Ayhan A. Sexual functions of Turkish women with gynecologic cancer

during the chemotherapy process. Asian Pac J Cancer Prev. 2013;14(6):3561-4.

doi: 10.7314/apjcp.2013.14.6.3561. PMID: 23886145.

100: Kucukoztas N, Dizdar O, Rahatli S, Dursun P, Yalcin S, Altundağ Ö, Ozen O,

Reyhan NH, Tarhan C, Yildiz F, Ayhan A. Impact of treatment strategies on local

control and survival in uterine carcinosarcomas in Turkey. Asian Pac J Cancer

Prev. 2013;14(5):2959-62. doi: 10.7314/apjcp.2013.14.5.2959. PMID: 23803061.

101: Terzi A, Aktaş IY, Dolgun A, Ayhan A, Küçükali T, Usubütün A. Early stage

epithelial ovarian cancers: a study of morphologic prognostic factors. Pathol

Res Pract. 2013 Jun;209(6):359-64. doi: 10.1016/j.prp.2013.03.009. Epub 2013 Mar

30. PMID: 23643734.

102: Takal MK, Baykal C, Başer E, Kaya MD, Dursun P, Ozen O, Haberal AN, Ayhan

A. Does Aquaporin-1 expression have clinical significance in serous epithelial

ovarian cancer? J Turk Ger Gynecol Assoc. 2013 Sep 1;14(3):130-5. doi:

10.5152/jtgga.2013.02679. PMID: 24592091; PMCID: PMC3928409.

103: Ayhan A, Başer E, Dursun P, Haberal AN. To what extent should we perform

parametrectomy in FIGO stage IB cervical cancer? J Turk Ger Gynecol Assoc. 2013

Jun 1;14(2):63-7. doi: 10.5152/jtgga.2013.05925. PMID: 24592076; PMCID:

PMC3881739.

104: Tepeoğlu M, Ozen O, Ayhan A. Ovarian serous borderline tumor detected by

conventional papanicolaou smear: a case report. Acta Cytol. 2013;57(1):96-9.

doi: 10.1159/000339007. Epub 2012 Dec 6. PMID: 23220864.

105: Fotopoulou C, Zang R, Gultekin M, Cibula D, Ayhan A, Liu D, Richter R,

Braicu I, Mahner S, Harter P, Trillsch F, Kumar S, Peiretti M, Dowdy SC,

Maggioni A, Trope C, Sehouli J. Value of tertiary cytoreductive surgery in

epithelial ovarian cancer: an international multicenter evaluation. Ann Surg

Oncol. 2013 Apr;20(4):1348-54. doi: 10.1245/s10434-012-2673-z. Epub 2012 Oct 2.

PMID: 23054114.

106: Dursun P, Erkanli S, Güzel AB, Gultekin M, Tarhan NC, Altundag O,

Demirkiran F, Beşe T, Yildirim Y, Bozdag G, Yarali H, Simsek T, Ozcelik B, Ortaç

F, Taskin S, Guvenal T, Ozgul N, Haberal A, Vardar MA, Dede M, Yenen M, Altintas

A, Arvas M, Ayhan A. A Turkish Gynecologic Oncology Group study of fertility-

sparing treatment for early-stage endometrial cancer. Int J Gynaecol Obstet.

2012 Dec;119(3):270-3. doi: 10.1016/j.ijgo.2012.06.010. Epub 2012 Aug 24. PMID:

22921272.

107: Pinar G, Ayhan A. Carcinomas associated with Lynch syndrome: a family

history. Int Surg. 2011 Oct-Dec;96(4):286-90. doi: 10.9738/cc15.1. PMID:

22808608.

108: Ayhan A, Dursun P, Karakaya BK, Ozen O, Tarhan C. Neoadjuvant chemotherapy

followed by cesarean radical hysterectomy in a triplet pregnancy complicated by

clear cell carcinoma of the cervix: a case presentation and literature review.

Int J Gynecol Cancer. 2012 Sep;22(7):1198-202. doi:

10.1097/IGC.0b013e31825e0d5a. PMID: 22801030.

109: Pinar G, Okdem S, Dogan N, Buyukgonenc L, Ayhan A. The effects of

hysterectomy on body image, self-esteem, and marital adjustment in Turkish women

with gynecologic cancer. Clin J Oncol Nurs. 2012 Jun 1;16(3):E99-104. doi:

10.1188/12.CJON.E99-E104. PMID: 22641334.

110: Gultekin M, Yildiz F, Ozyigit G, Beyaz H, Hayran M, Kose F, Yuce K, Ayhan

A. Comparison of FIGO 1988 and 2009 staging systems for endometrial carcinoma.

Med Oncol. 2012 Dec;29(4):2955-62. doi: 10.1007/s12032-012-0196-x. Epub 2012 Mar

14. PMID: 22415398.

111: Dursun P, Bildaci TB, Zeyneloglu HB, Kuscu E, Ayhan A. Transobturator tape

operation is more effective in premenopausal women than in postmenopausal women

with stress incontinence. Korean J Urol. 2011 Sep;52(9):612-5. doi:

10.4111/kju.2011.52.9.612. Epub 2011 Sep 28. PMID: 22025956; PMCID: PMC3198234.

112: Pinar G, Okdem S, Buyukgonenc L, Ayhan A. The relationship between social

support and the level of anxiety, depression, and quality of life of Turkish

women with gynecologic cancer. Cancer Nurs. 2012 May-Jun;35(3):229-35. doi:

10.1097/NCC.0b013e31822c47bd. PMID: 21946902.

113: Dursun P, Gultekin M, Ayhan A. World gynecologic oncology publications and

the Turkish contribution to the literature between 2000 and 2007. Asian Pac J

Cancer Prev. 2011;12(4):861-4. PMID: 21790216.

114: Tian WJ, Chi DS, Sehouli J, Tropé CG, Jiang R, Ayhan A, Cormio G, Xing Y,

Breitbach GP, Braicu EI, Rabbitt CA, Oksefjell H, Fotopoulou C, Meerpohl HG, du

Bois A, Berek JS, Zang RY, Harter P. A risk model for secondary cytoreductive

surgery in recurrent ovarian cancer: an evidence-based proposal for patient

selection. Ann Surg Oncol. 2012 Feb;19(2):597-604. doi:

10.1245/s10434-011-1873-2. Epub 2011 Jul 6. PMID: 21732142.

115: Dursun P, Yanik FB, Zeyneloglu HB, Baser E, Kuscu E, Ayhan A. Why women

request cesarean section without medical indication? J Matern Fetal Neonatal

Med. 2011 Sep;24(9):1133-7. doi: 10.3109/14767058.2010.531327. Epub 2011 Jun 13.

PMID: 21668323.

116: Erkanli S, Ayhan A. Fertility-sparing therapy in young women with

endometrial cancer: 2010 update. Int J Gynecol Cancer. 2010 Oct;20(7):1170-87.

doi: 10.1111/igc.0b013e3181e94f5a. PMID: 21495221.

117: Dursun P, Gultekin M, Ayhan A. The history of radical hysterectomy. J Low

Genit Tract Dis. 2011 Jul;15(3):235-45. doi: 10.1097/LGT.0b013e31820eb038. PMID:

21427603.

118: Baser E, Can F, Unlukaplan M, Ayhan A. Lymph node human papillomavirus DNA

positivity in uterine cervical cancers and its relationship with prognostic

factors. Int J Gynecol Cancer. 2011 Jan;21(1):117-22. doi:

10.1111/IGC.0b013e3181fe8b88. PMID: 21330836.

119: Macuks R, Ozdemir H, Dursun P, Ozen OI, Haberal N, Ayhan A. Malignant

intraperitoneal mesothelioma-Başkent University experience. J Turk Ger Gynecol

Assoc. 2011 Jun 1;12(2):104-9. doi: 10.5152/jtgga.2011.24. PMID: 24591971;

PMCID: PMC3939100.

120: Desteli GA, Gultekin M, Usubutun A, Yuce K, Ayhan A. Lymph node metastasis

in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe

experience and review of literature. World J Surg Oncol. 2010 Nov 30;8:106. doi:

10.1186/1477-7819-8-106. PMID: 21114870; PMCID: PMC3002346.

121: Altundag O, Dursun P, Ayhan A. Emerging drugs in endometrial cancers.

Expert Opin Emerg Drugs. 2010 Dec;15(4):557-68. doi:

10.1517/14728214.2010.517521. Epub 2010 Sep 9. PMID: 20828226.

122: Ayhan A, Basaran A, Güler TO. Effects of oxidized regenerated

methylcellulose on lymphocyst formation and peritoneum in gynecologic cancer

patients. Int J Gynecol Cancer. 2010 Jan;20(1):23-7. doi:

10.1111/IGC.0b013e3181be698f. PMID: 20130499.

123: Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A. Human papillomavirus (HPV)

prevalence and types among Turkish women at a gynecology outpatient unit. BMC

Infect Dis. 2009 Nov 30;9:191. doi: 10.1186/1471-2334-9-191. PMID: 19948015;

PMCID: PMC2789077.

124: Nar A, Demirtas E, Ayhan A, Gurlek A. Effects of bilateral ovariectomy and

estrogen replacement therapy on serum leptin, sex hormone binding globulin and

insulin like growth factor-I levels. Gynecol Endocrinol. 2009 Dec;25(12):773-8.

doi: 10.3109/09513590903159532. PMID: 19905995.

125: Usubütün A, Alemany L, Küçükali T, Ayhan A, Yüce K, de Sanjosé S, Font R,

Lloveras B, Klaustermeier J, Quint W, Muñoz N, Bosch FX. Human papillomavirus

types in invasive cervical cancer specimens from Turkey. Int J Gynecol Pathol.

2009 Nov;28(6):541-8. doi: 10.1097/PGP.0b013e3181aaba0d. PMID: 19851201.

126: Kara PP, Ayhan A, Caner B, Gultekin M, Ugur O, Bozkurt MF, Usubutun A, Uner

A. Analysis of dendritic cells in sentinel lymph nodes of patients with

endometrial and patients with cervical cancers. Int J Gynecol Cancer. 2009

Oct;19(7):1239-43. doi: 10.1111/IGC.0b013e3181b3e616. PMID: 19823061.

127: Ayhan A, Salman MC, Velipasaoglu M, Sakinci M, Yuce K. Prognostic factors

in adult granulosa cell tumors of the ovary: a retrospective analysis of 80

cases. J Gynecol Oncol. 2009 Sep;20(3):158-63. doi: 10.3802/jgo.2009.20.3.158.

Epub 2009 Sep 30. PMID: 19809549; PMCID: PMC2757560.

128: Turkish Cervical Cancer And Cervical Cytology Research Group. Prevalence of

cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet. 2009

Sep;106(3):206-9. doi: 10.1016/j.ijgo.2009.04.003. Epub 2009 Jun 21. PMID:

19541303.

129: Dursun P, Altuntas B, Kuscu E, Ayhan A. Women's knowledge about human

papillomavirus and their acceptance of HPV vaccine. Aust N Z J Obstet Gynaecol.

2009 Apr;49(2):202-6. doi: 10.1111/j.1479-828X.2009.00947.x. PMID: 19432612.

130: Gultekin M, Dursun P, Doğan NU, Kolusari A, Yuce K, Ayhan A. Debulking

surgery for incompletely operated advanced epithelial ovarian carcinoma. J Surg

Oncol. 2009 Sep 1;100(3):258-60. doi: 10.1002/jso.21274. PMID: 19347889.

131: Bozdag G, Yarali H, Polat M, Esinler I, Tiras B, Ayhan A. ICSI outcome

following conservative fertility sparing management of endometrial cancer.

Reprod Biomed Online. 2009 Mar;18(3):416-20. doi: 10.1016/s1472-6483(10)60102-2.

PMID: 19298743.

132: Yenen MC, Dede M, Alanbay I, Ustün Y, Gültekin M, Ayhan A. Port-site

metastasis after laparoscopic extraperitoneal paraaortic lymphadenectomy for

stage IIb squamous cell carcinoma of the cervix. J Minim Invasive Gynecol. 2009

Mar-Apr;16(2):227-30. doi: 10.1016/j.jmig.2008.12.010. PMID: 19249716.

133: Ayhan A, Dogan NU, Guven S, Guler OT, Boynukalin FK, Salman MC. Clinical

outcome of transobturator tape concomitant with vaginal hysterectomy plus

anterior posterior colporrhaphy. Arch Gynecol Obstet. 2009 Sep;280(3):375-80.

doi: 10.1007/s00404-008-0920-0. Epub 2009 Jan 16. PMID: 19148661.

134: Ayhan A, Boynukalin FK, Guven S, Dogan NU, Esinler I, Usubutun A. Repeat

LEEP conization in patients with cervical intraepithelial neoplasia grade 3 and

positive ectocervical margins. Int J Gynaecol Obstet. 2009 Apr;105(1):14-7. doi:

10.1016/j.ijgo.2008.11.015. Epub 2008 Dec 25. PMID: 19111301.

135: Ayhan A, Aksan G, Gultekin M, Esin S, Himmetoglu C, Dursun P, Usubutun A,

Yuce K. Prognosticators and the role of lymphadenectomy in uterine

leiomyosarcomas. Arch Gynecol Obstet. 2009 Jul;280(1):79-85. doi:

10.1007/s00404-008-0876-0. Epub 2008 Dec 19. PMID: 19096861.

136: Ayhan A, Velipasaoglu M, Salman MC, Guven S, Gultekin M, Bayraktar O.

Prognostic factors for recurrence and survival in primary vulvar squamous cell

cancer. Acta Obstet Gynecol Scand. 2008;87(11):1143-9. doi:

10.1080/00016340802506305. PMID: 18949585.

137: Ayhan A, Gultekin M, Sağlam EA, Dursun P, Dogan NU, Aksan G, Usubutun A,

Yuce K. Depth of invasion for appendiceal metastasis of ovarian cancers: does it

have any clinical significance? J Obstet Gynaecol Res. 2008 Aug;34(4):557-60.

doi: 10.1111/j.1447-0756.2008.00816.x. PMID: 18937709.

138: Gultekin M, Velipaşaoğlu M, Aksan G, Dursun P, Dogan NU, Yuce K, Ayhan A. A

third evaluation of tertiary cytoreduction. J Surg Oncol. 2008 Dec

1;98(7):530-4. doi: 10.1002/jso.21146. PMID: 18937233.

139: Dursun P, Ayhan A, Kuscu E. Nerve-sparing radical hysterectomy for cervical

carcinoma. Crit Rev Oncol Hematol. 2009 Jun;70(3):195-205. doi:

10.1016/j.critrevonc.2008.09.003. Epub 2008 Oct 15. PMID: 18926716.

140: Kara PP, Ayhan A, Caner B, Gültekin M, Ugur O, Bozkurt MF, Usubutun A.

Sentinel lymph node detection in early stage cervical cancer: a prospective

study comparing preoperative lymphoscintigraphy, intraoperative gamma probe, and

blue dye. Ann Nucl Med. 2008 Jul;22(6):487-94. doi: 10.1007/s12149-008-0144-1.

Epub 2008 Aug 1. PMID: 18670855.

141: Ozlü T, Ozlü MF, Ayhan A. Spontaneous ovarian hematoma in a patient treated

with clopidogrel. Int J Gynaecol Obstet. 2008 Sep;102(3):293-4. doi:

10.1016/j.ijgo.2008.03.016. Epub 2008 May 27. PMID: 18501904.

142: Ayhan A, Celik H, Dursun P. Lymphatic mapping and sentinel node biopsy in

gynecological cancers: a critical review of the literature. World J Surg Oncol.

2008 May 20;6:53. doi: 10.1186/1477-7819-6-53. PMID: 18492253; PMCID:

PMC2409335.

143: Dursun P, Ayhan A, Tarhan NC, Coban G, Kuscu E. Cerebellar metastasis in

squamous cell vulvar carcinoma. Arch Gynecol Obstet. 2009 Jan;279(1):69-71. doi:

10.1007/s00404-008-0635-2. Epub 2008 Apr 1. PMID: 18379804.

144: Ayhan A, Gultekin M, Dursun P, Dogan NU, Aksan G, Guven S, Velipasaoglu M,

Yuce K. Metastatic lymph node number in epithelial ovarian carcinoma: does it

have any clinical significance? Gynecol Oncol. 2008 Feb;108(2):428-32. doi:

10.1016/j.ygyno.2007.09.014. PMID: 18249232.

145: Saglam A, Bozdag G, Kuzey GM, Kuçukali T, Ayhan A. Four synchronous female

genital malignancies: the ovary, cervix, endometrium and fallopian tube. Arch

Gynecol Obstet. 2008 Jun;277(6):557-62. doi: 10.1007/s00404-007-0520-4. PMID:

18066567.

146: Ayhan A, Gultekin M, Dursun P, Dogan NU, Aksan G, Guven S, Yuce K.

Predictors and outcomes of recurrent disease after a negative second look

laparotomy. J Surg Oncol. 2008 Mar 1;97(3):226-30. doi: 10.1002/jso.20933. PMID:

18050284.

147: Gurgan T, Bozdag G, Demirol A, Ayhan A. Preserving fertility before

assisted reproduction in women with endometrial carcinoma: case report and

literature review. Reprod Biomed Online. 2007 Nov;15(5):561-5. doi:

10.1016/s1472-6483(10)60389-6. PMID: 18028748.

148: Basaran A, Ayhan A. Cancer of the vagina treated with wide local excision

and modified Martius (labial) flap interposition. Gynecol Oncol. 2008

Feb;108(2):455-6. doi: 10.1016/j.ygyno.2007.10.010. Epub 2007 Nov 19. PMID:

18006048.

149: Vergote I, van der Zee AG, Kesic V, Sert B, Robova H, Rob L, Reed N,

Luesley DM, Leblanc E, Hagen B, Gitsch G, du Bois A, di Vagno G, Colombo N,

Beller U, Ayhan A, Jacobs I. ESGO statement on cervical cancer vaccination. Int

J Gynecol Cancer. 2007 Nov-Dec;17(6):1183-5. doi:

10.1111/j.1525-1438.2007.01129.x. PMID: 17997794.

150: Usubütün A, Ozseker HS, Himmetoglu C, Balci S, Ayhan A. Omentectomy for

gynecologic cancer: how much sampling is adequate for microscopic examination?

Arch Pathol Lab Med. 2007 Oct;131(10):1578-81. doi:

10.5858/2007-131-1578-OFGCHM. PMID: 17922596.

151: Doğan-Ekici AI, Usubütün A, Küçükali T, Ayhan A. Xanthogranulomatous

endometritis: a challenging imitator of endometrial carcinoma. Infect Dis Obstet

Gynecol. 2007;2007:34763. doi: 10.1155/2007/34763. PMID: 17710239; PMCID:

PMC1939916.

152: Yildiz IZ, Usubütün A, Firat P, Ayhan A, Küçükali T. Efficiency of

immunohistochemical p16 expression and HPV typing in cervical squamous

intraepithelial lesion grading and review of the p16 literature. Pathol Res

Pract. 2007;203(6):445-9. doi: 10.1016/j.prp.2007.03.010. Epub 2007 May 31.

PMID: 17543474.

153: Ayhan A, Guven ES, Guven S, Sakinci M, Dogan NU, Kucukali T. Testosterone

versus clobetasol for maintenance of vulvar lichen sclerosus associated with

variable degrees of squamous cell hyperplasia. Acta Obstet Gynecol Scand.

2007;86(6):715-9. doi: 10.1080/00016340701292809. PMID: 17520405.

154: Ayhan A, Guven S, Guven ES, Kucukali T. Is there a correlation between

tumor marker panel and tumor size and histopathology in well staged patients

with borderline ovarian tumors? Acta Obstet Gynecol Scand. 2007;86(4):484-90.

doi: 10.1080/00016340701226138. PMID: 17486473.

155: Ayhan A, Dursun P, Gultekin M, Yuce K. Comparison of midline and

Pfannenstiel incision for radical hysterectomy with pelvic and paraaortic

lymphadenectomy in cervical carcinoma. J Obstet Gynaecol Res. 2007

Apr;33(2):161-5. doi: 10.1111/j.1447-0756.2007.00501.x. PMID: 17441889.

156: Ayhan A, Gultekin M, Celik NY, Dursun P, Taskiran C, Aksan G, Yuce K.

Occult metastasis in early ovarian cancers: risk factors and associated

prognosis. Am J Obstet Gynecol. 2007 Jan;196(1):81.e1-6. doi:

10.1016/j.ajog.2006.08.043. PMID: 17240245.

157: Demirol A, Guven S, Guvendag Guven ES, Kirazli S, Gurgan T, Ayhan A.

Comparison of the effects of tibolone and estrogen therapy on hemostasis in

surgical menopause: a randomized, double-blind, placebo-controlled study. Fertil

Steril. 2007 Apr;87(4):842-8. doi: 10.1016/j.fertnstert.2006.08.090. Epub 2007

Jan 12. PMID: 17222829.

158: Akhan O, Karcaaltincaba M, Ozmen MN, Akinci D, Karcaaltincaba D, Ayhan A.

Percutaneous transcatheter ethanol sclerotherapy and catheter drainage of

postoperative pelvic lymphoceles. Cardiovasc Intervent Radiol. 2007 Mar-

Apr;30(2):237-40. doi: 10.1007/s00270-006-0180-y. PMID: 17205362.

159: Ayhan A, Bozdag G, Taskiran C, Gultekin M, Yuce K, Kucukali T. The value of

preoperative platelet count in the prediction of cervical involvement and poor

prognostic variables in patients with endometrial carcinoma. Gynecol Oncol. 2006

Dec;103(3):902-5. doi: 10.1016/j.ygyno.2006.05.034. Epub 2006 Jul 10. PMID:

16828847.

160: Ayhan A, Otegen U, Guven S, Kucukali T. Radical reoperation for invasive

cervical cancer found in simple hysterectomy. J Surg Oncol. 2006 Jul

1;94(1):28-34. doi: 10.1002/jso.20550. PMID: 16788940.

161: Ayhan A, Kart C, Guven S, Boynukalin K, Kucukali T. The role of reoperation

in the management of endometrial carcinoma found in simple hysterectomy. J Surg

Oncol. 2006 Apr 1;93(5):373-8. doi: 10.1002/jso.20479. PMID: 16550570.

162: Salman MC, Ayhan A. Use of anti-thrombotic agents during chemotherapy for

epithelial ovarian cancer. Med Hypotheses. 2006;66(6):1179-81. doi:

10.1016/j.mehy.2005.11.044. Epub 2006 Jan 30. PMID: 16446052.

163: Taskiran C, Aktas D, Yigit-Celik N, Alikasifoglu M, Yuce K, Tunçbilek E,

Ayhan A. CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial

neoplasia and invasive cervical cancer. Gynecol Oncol. 2006 Jun;101(3):503-6.

doi: 10.1016/j.ygyno.2005.11.018. Epub 2006 Jan 5. PMID: 16403567.

164: Ayhan A, Gultekin M, Taskiran C, Aksan G, Celik NY, Dursun P, Salman MC,

Yuce K, Kucukali T. The role of secondary cytoreduction in the treatment of

ovarian cancer: Hacettepe University experience. Am J Obstet Gynecol. 2006

Jan;194(1):49-56. doi: 10.1016/j.ajog.2005.06.048. PMID: 16389009.

165: Saglam EA, Usubütün A, Ayhan A, Küçükali T. Mistakes prevent mistakes:

experience from intraoperative consultation with frozen section. Eur J Obstet

Gynecol Reprod Biol. 2006 Apr 1;125(2):266-8. doi: 10.1016/j.ejogrb.2005.10.015.

Epub 2005 Nov 21. PMID: 16303231.

166: Karcaaltincaba M, Karcaaltincaba D, Ayhan A. Diagnosis of tailgut cysts.

AJR Am J Roentgenol. 2005 Nov;185(5):1369-70. doi: 10.2214/AJR.05.5148. PMID:

16247171.

167: Usubütün A, Karaman N, Ayhan A, Küçükali T. Atypical endometrial stromal

cells related with a polypoid leiomyoma with bizarre nuclei: a case report. Int

J Gynecol Pathol. 2005 Oct;24(4):352-4. doi: 10.1097/01.pgp.0000166996.57196.cb.

PMID: 16175081.

168: Dursun P, Gultekin M, Yuce K, Ayhan A. What is the underlying cause of

aneuploidy associated with increasing maternal age? Is it associated with

elevated levels of gonadotropins? Med Hypotheses. 2006;66(1):143-7. doi:

10.1016/j.mehy.2004.10.022. Epub 2005 Sep 2. PMID: 16140466.

169: Ayhan A, Taskiran C, Bozdag G, Altinbas S, Altinbas A, Yuce K. Endodermal

sinus tumor of the ovary: the Hacettepe University experience. Eur J Obstet

Gynecol Reprod Biol. 2005 Dec 1;123(2):230-4. doi: 10.1016/j.ejogrb.2005.04.021.

Epub 2005 Jul 18. PMID: 16026921.

170: Saglam EA, Usubütün A, Kart C, Ayhan A, Küçükali T. Reactive nodular

fibrous pseudotumor involving the pelvic and abdominal cavity: a case report and

review of literature. Virchows Arch. 2005 Nov;447(5):879-82. doi:

10.1007/s00428-005-0027-y. Epub 2005 Jul 14. PMID: 16021510.

171: Ayhan A, Guvendag Guven ES, Guven S, Kucukali T. Recurrence and prognostic

factors in borderline ovarian tumors. Gynecol Oncol. 2005 Sep;98(3):439-45. doi:

10.1016/j.ygyno.2005.05.033. PMID: 16009407.

172: Dursun P, Gultekin M, Bozdag G, Usubutun A, Uner A, Celik NY, Yuce K, Ayhan

A. Primary cervical lymphoma: report of two cases and review of the literature.

Gynecol Oncol. 2005 Sep;98(3):484-9. doi: 10.1016/j.ygyno.2005.04.040. PMID:

15992915.

173: Dursun P, Yuce K, Ayhan A. Insulin-like growth factors (IGFs) in ovarian

carcinoma. Gynecol Oncol. 2005 Nov;99(2):523; author reply 523-4. doi:

10.1016/j.ygyno.2005.04.022. Epub 2005 Jun 20. PMID: 15967488.

174: Ayhan A, Gultekin M, Taskiran C, Celik NY, Usubutun A, Kucukali T, Yuce K.

Lymphatic metastasis in epithelial ovarian carcinoma with respect to

clinicopathological variables. Gynecol Oncol. 2005 May;97(2):400-4. doi:

10.1016/j.ygyno.2005.01.038. PMID: 15863136.

175: Guvendag Guven ES, Guven S, Coskun F, Ayhan A, Sener C. Angle closure

glaucoma induced by ritodrine. Acta Obstet Gynecol Scand. 2005 May;84(5):489-90.

doi: 10.1111/j.0001-6349.2005.0243a.x. PMID: 15842216.

176: Salman MC, Basaran A, Guler T, Gultekin M, Dursun P, Karcaaltincaba M, Kes

S, Ayhan A. Meigs' syndrome with highly elevated ca. 125 levels in a patient

with Takayasu arteritis: a case report. Arch Gynecol Obstet. 2005

Jun;272(1):90-2. doi: 10.1007/s00404-005-0735-1. Epub 2005 Apr 7. PMID:

15815942.

177: Ayhan A, Gultekin M, Taskiran C, Salman MC, Celik NY, Yuce K, Usubutun A,

Kucukali T. Routine appendectomy in epithelial ovarian carcinoma: is it

necessary? Obstet Gynecol. 2005 Apr;105(4):719-24. doi:

10.1097/01.AOG.0000154884.20872.c4. PMID: 15802396.

178: Dursun P, Yuce K, Gunalp S, Ayhan A. Oxytocin and osteoporosis: is there

any relationship? Med Hypotheses. 2005;64(5):1060-1. doi:

10.1016/j.mehy.2004.11.008. PMID: 15780511.

179: Dursun P, Gultekin M, Yuce K, Ayhan A. Lower expression of

cyclooxygenase-2: is it associated with the development of borderline ovarian

tumors? Med Hypotheses. 2005;64(2):273-8. doi: 10.1016/j.mehy.2004.06.031. PMID:

15607554.

180: Guven S, Guven ES, Ayhan A. Vulvar edema as a rare complication of

laparoscopy. J Am Assoc Gynecol Laparosc. 2004 Aug;11(3):429-32. doi:

10.1016/s1074-3804(05)60061-8. PMID: 15559359.

181: Ayhan A, Salman MC, Celik H, Dursun P, Ozyuncu O, Gultekin M. Association

between fertility drugs and gynecologic cancers, breast cancer, and childhood

cancers. Acta Obstet Gynecol Scand. 2004 Dec;83(12):1104-11. doi:

10.1111/j.0001-6349.2004.00669.x. PMID: 15548140.

182: Onderoglu LS, Gültekin M, Dursun P, Karcaaltincaba M, Usubutun A, Akata D,

Ayhan A. Bilateral ovarian fibromatosis presenting with ascites and hirsutism.

Gynecol Oncol. 2004 Jul;94(1):223-5. doi: 10.1016/j.ygyno.2004.03.042. PMID:

15262147.

183: Ayhan A, Taskiran C, Celik C, Yuce K. The long-term survival of women with

surgical stage II endometrioid type endometrial cancer. Gynecol Oncol. 2004

Apr;93(1):9-13. doi: 10.1016/j.ygyno.2003.11.018. PMID: 15047207.

184: Demirtas E, Guven S, Guven ES, Baykal C, Ayhan A. Two successful

spontaneous pregnancies in a patient with a primary primitive neuroectodermal

tumor of the ovary. Fertil Steril. 2004 Mar;81(3):679-81. doi:

10.1016/j.fertnstert.2003.08.036. PMID: 15037420.

185: Dursun P, Salman MC, Taskiran C, Usubutun A, Ayhan A. Primary